The effective F-1 registration signals an imminent capital raise for this micro-cap biotech. Traders should expect a priced offering within days, likely causing significant dilution given the $1M market cap. Monitor for the prospectus (424B) filing to assess terms and size.
Price Chart
Executive Summary
Biodexa Pharmaceuticals Plc's F-1 registration statement (File No. 333-297473) became effective on August 3, 2026, allowing the company to proceed with a securities offering. Given the company's $1M market cap and pre-revenue status, this effectiveness opens the door to potentially dilutive capital raising, which is a material event for a micro-cap biotech.
Key Facts
- F-1 registration statement (File No. 333-297473) declared effective on August 3, 2026.
- Company is a micro-cap biotech with a $1M market cap.
- Effectiveness allows immediate sale of securities, creating dilution overhang.
- Cross-filing actuarial verdict confirms amplifier effect for IPO-context + shelf-context combination.
Financial Impact
Potential dilution from an offering of undisclosed amount; company market cap is $1M, so any offering is proportionally significant.
Risk Factors
- Dilution from the upcoming offering could be severe relative to current market cap.
- Pre-revenue biotech with no disclosed pipeline catalysts to offset dilution.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002525 |
| Document: 9999999995-26-002525-index.html | 9999999995-26-002525 |
| Document: 9999999995-26-002525.txt | 9999999995-26-002525 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 13d ago | 6-K | $0.4849 | awaiting T+20 | — | $3.69 (+660.98%) |
Oct 8, 2026 18d ago | 6-K | $0.4602 | awaiting T+20 | — | $3.69 (+701.83%) |
Oct 1, 2026 26d ago | EFFECT | $0.6326 | awaiting T+20 | — | $3.69 (−483.31%) |
Sep 24, 2026 4w ago | F-1 | $0.6750 $0.4140 | ▲ +38.67% | ▲ +38.25% | $3.69 (−446.67%) |
Sep 15, 2026 6w ago | 6-K | $1.33 $0.3502 | ▼ −73.67% | ▼ −76.65% | $3.69 (+177.44%) |
Sep 11, 2026 6w ago | 6-K | $1.12 $0.3832 | ▲ +65.79% | ▲ +68.05% | $3.69 (−229.46%) |
Aug 4, 2026 12w ago | EFFECT | $11.92 $6.25 | ▲ +47.58% | ▲ +46.35% | $3.69 (+69.04%) |
Jun 30, 2026 16w ago | 6-K | $3.00 $1.45 | ▼ −51.83% | ▼ −49.65% | $3.69 (+23.00%) |
Jun 30, 2026 16w ago | 6-K | $2.91 $1.45 | ▲ +50.34% | ▲ +48.03% | $3.69 (−26.80%) |
Jun 17, 2026 18w ago | 6-K | $3.06 $2.13 | ▼ −30.39% | ▼ −30.93% | $3.69 (+20.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers